期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CTS-Clinical and Translational Science LetPub Score 6.2
50 ratings
Rate
Reputation 7.1 Influence 5.0 Speed 8.8 | ||||||||||||||||||||||||
期刊簡稱 | CTS-CLIN TRANSL SCI | ||||||||||||||||||||||||
ISSN | 1752-8054 | ||||||||||||||||||||||||
E-ISSN | 1752-8062 | ||||||||||||||||||||||||
h-index | 35 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062 | ||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/cts | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2008 | ||||||||||||||||||||||||
每年文章數 | 211每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 77.43% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD3300; GBP4500; EUR3800; ) APC waiver:Check Notes Other charges: No Keywords: translational medicine、precision medicine、translational studies、quantitative pharmacology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1752-8054%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CTS-Clinical and Translational Science] 的評論 | 撰寫評論 |
作者: Udo 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-09-06 10:31:46 評論於 Submitted on June 9, 2023, first revision on July 15, second revision on August 25, and accepted on September 1(0) 讚! | Udo |
作者: 西域梦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-23 20:17:08 評論於 Probably looking for reviewers(0) 讚! | 西域梦露 |
作者: 是你的竹月呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-21 21:56:52 評論於 Research Focus: Tumors; Sharing of Clinical Basic Research Experience: Does anyone know at which stage this is? Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023(0) 讚! | 是你的竹月呀 |
作者: 西域梦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-07 13:33:29 評論於 Has your status changed? Why has it been under consideration all this time?(0) 讚! | 西域梦露 |
作者: Nora Wilhelmina 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-23 15:41:57 評論於 How long does it usually take for this magazine to review the manuscript? After submission, does the submission status remain unchanged?(0) 讚! | Nora Wilhelmina |
作者: 西域梦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-20 21:41:56 評論於 Is there any update on this? Will the corresponding author receive an email after submitting a manuscript to this journal?(0) 讚! | 西域梦露 |
作者: 碧桃泉润 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-20 09:24:54 評論於 My application also went from under consideration to under consideration again after a month and a half. How did it go for you afterwards?(0) 讚! | 碧桃泉润 |
作者: 极乐新林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-27 11:43:39 評論於 Is there any update?(0) 讚! | 极乐新林 |
作者: 极乐新林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-21 22:24:09 評論於 What happened afterwards?(0) 讚! | 极乐新林 |
作者: 极乐新林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 15:23:32 評論於 Can we have dual communication?(0) 讚! | 极乐新林 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:25:49 評論於 Research Background, Significance, and Development Status: With the advancement of technology and the increasing complexity of social issues, the need for interdisciplinary research has become increasingly evident. This has led to a growing interest in exploring the interactions between different fields of study and finding innovative solutions to real-world problems. However, despite the progress that has been made in this area, there are still many challenges that need to be addressed in order to fully capitalize on the potential of interdisciplinary research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:32:09 評論於 Important literature, if available, can be referenced to illustrate both points, but can highlight the differences in emphasis between the two(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:02:35 評論於 What does the introduction three-part structure refer to?(0) 讚! | 魂魄彦露 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 11:42:07 評論於 Is the important literature in the results or described in the introduction?(0) 讚! | 八坂篷蔚 |
作者: 奥维超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-08 23:14:26 評論於 My paper is a clinical article, without requiring me to provide any other data(0) 讚! | 奥维超级甜 |
作者: 奥维超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-08 19:16:56 評論於 The review process with peer reviewers' feedback is indeed faster(0) 讚! | 奥维超级甜 |
作者: 新荣mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-15 09:35:00 評論於 It has been a month and a half since I submitted it and it is still in the review stage(0) 讚! | 新荣mio |
作者: 新荣mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-10 11:20:09 評論於 Can anyone share experience on the Half a month StageStart Date 11-23-2020 UnderConsideration 11-16-2020 Submission 11-13-2020 UnderConsideration 11-13-2020 Submission 11-12-2020(0) 讚! | 新荣mio |
作者: 新荣mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-19 13:06:52 評論於 Review in just five days? Is this journal so fast? Could it be that they accepted it before it even left the editorial department?(0) 讚! | 新荣mio |
作者: 蒙德凌柏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-31 22:38:59 評論於 Hello, may I ask if it is necessary to prepare relevant raw data for submitting to this magazine? My article is a clinical one with a bit of basic research(0) 讚! | 蒙德凌柏 |
作者: 奥维超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-13 10:15:50 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: For a clinical research article, submitted on April 11th, received an email for minor revisions in the early morning of the 16th, with four or five suggestions, required to return the revised version within a week. The revisions were completed on the same day, and the acceptance email was received on the 17th, along with proofs, very efficient. The publication fee is 3000 USD. Official data shows receiving 1500+ papers annually, with an acceptance rate of 10%(0) 讚! | 奥维超级甜 |
作者: xqsong2012@126.com 領域: 生命科学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2017-04-20 13:56:41 評論於 Has anyone submitted to this journal? My manuscript recently got accepted, but I’m not happy about it. I want to withdraw the manuscript. The page fee is $3,000… really?! (0) 讚! | xqsong2012@126.com |
作者: 洗髓碧菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-20 08:18:20 評論於 Has anyone submitted to this magazine before? Although mine was accepted, I can't be happy at all. I'm thinking about withdrawing the submission. The publication fee is $3000, and there is no discount(0) 讚! | 洗髓碧菡 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us